Michael I Koukourakis Selected Research

Michael I Koukourakis Research Topics

Disease

101	Neoplasms (Cancer) 04/2022 - 01/2002
43	Hypoxia (Hypoxemia) 11/2020 - 08/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2003
19	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
16	Adenocarcinoma 01/2021 - 07/2002
15	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 09/2004
13	Neoplasm Metastasis (Metastasis) 05/2022 - 09/2003
12	Carcinoma (Carcinomatosis) 11/2019 - 04/2002
12	Lung Neoplasms (Lung Cancer) 09/2019 - 06/2003
10	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 08/2002
9	Colorectal Neoplasms (Colorectal Cancer) 07/2011 - 05/2002
8	Endometrial Neoplasms (Endometrial Cancer) 01/2015 - 04/2002
6	Fever (Fevers) 06/2011 - 01/2002
6	Exanthema (Rash) 06/2011 - 01/2002
5	Necrosis 01/2022 - 09/2003
5	Urinary Bladder Neoplasms (Bladder Cancer) 08/2020 - 02/2007
4	Rectal Neoplasms (Rectal Cancer) 05/2022 - 09/2008
4	Squamous Cell Carcinoma of Head and Neck 01/2022 - 02/2006
4	Fibrosis (Cirrhosis) 06/2014 - 01/2007
4	Melanoma (Melanoma, Malignant) 01/2012 - 10/2003
3	Lymphopenia (Lymphocytopenia) 03/2021 - 07/2002
3	Pneumonia (Pneumonitis) 07/2020 - 06/2009
3	Sarcoma (Soft Tissue Sarcoma) 02/2020 - 12/2003
3	Anemia 09/2019 - 05/2004
3	Neutropenia 09/2019 - 07/2002
3	Glioblastoma (Glioblastoma Multiforme) 08/2018 - 01/2014
3	Xerostomia 01/2018 - 11/2005
3	Carcinogenesis 02/2017 - 05/2004
3	B-Cell Lymphoma (Lymphoma, B Cell) 03/2013 - 11/2008
3	Proctitis 10/2012 - 09/2008
3	Ductal Carcinoma 06/2006 - 01/2003
3	Hypotension (Low Blood Pressure) 02/2006 - 08/2003
2	Diarrhea 09/2019 - 06/2011
2	Acidosis 07/2019 - 07/2006
2	Stomach Neoplasms (Stomach Cancer) 12/2018 - 09/2010

Drug/Important Bio-Agent (IBA)

45	Proteins (Proteins, Gene)FDA Link 04/2022 - 08/2002
34	Amifostine (Ethyol)FDA LinkGeneric 01/2021 - 01/2002
29	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 04/2002
11	Biological ProductsIBA 01/2022 - 09/2004
11	EnzymesIBA 08/2021 - 04/2002
10	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 01/2006
10	Lactate Dehydrogenase 5IBA 01/2016 - 01/2005
9	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2020 - 08/2003
9	Oxygen (Dioxygen)IBA 01/2015 - 05/2004
8	Carbonic Anhydrase IXIBA 01/2020 - 09/2003
7	Docetaxel (Taxotere)FDA Link 08/2021 - 07/2002
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2006
7	ParaffinIBA 11/2020 - 01/2008
7	Thymidine PhosphorylaseIBA 11/2012 - 04/2002
6	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 03/2005
6	Monoclonal AntibodiesIBA 08/2020 - 05/2002
6	IsoenzymesIBA 01/2019 - 08/2003
6	Transcription Factors (Transcription Factor)IBA 01/2017 - 10/2003
6	Lactic Acid (Lactate)FDA LinkGeneric 11/2012 - 01/2005
5	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2018 - 01/2005
5	Oxidoreductases (Dehydrogenase)IBA 10/2016 - 01/2005
4	LigandsIBA 04/2022 - 04/2013
4	Biomarkers (Surrogate Marker)IBA 08/2021 - 08/2009
4	Beclin-1IBA 12/2018 - 06/2011
4	Cathepsin DIBA 01/2018 - 01/2014
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 03/2006
4	Pyruvic Acid (Pyruvate)IBA 10/2016 - 01/2005
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2012 - 05/2006
4	Indicators and Reagents (Reagents)IBA 11/2011 - 02/2006
3	AntigensIBA 01/2022 - 05/2004
3	Hormones (Hormone)IBA 11/2021 - 01/2006
3	Carbon DioxideIBA 01/2020 - 10/2006
3	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2020 - 02/2006
3	MicroRNAs (MicroRNA)IBA 10/2018 - 01/2015
3	PlatinumIBA 01/2018 - 12/2003
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2016 - 01/2006
3	Capecitabine (Xeloda)FDA Link 06/2011 - 09/2008
3	Bevacizumab (Avastin)FDA Link 06/2011 - 06/2007
3	Estrogens (Estrogen)FDA Link 09/2010 - 03/2006
3	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2007 - 04/2002
2	Perilipin-3IBA 01/2022 - 08/2021
2	apalutamideIBA 11/2021 - 01/2018
2	bicalutamide (Casodex)FDA LinkGeneric 11/2021 - 01/2018
2	Chloroquine (Aralen)FDA LinkGeneric 08/2021 - 11/2011
2	B7-H1 AntigenIBA 05/2021 - 10/2018
2	Aldehyde DehydrogenaseIBA 01/2021 - 01/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 07/2020
2	LipofuscinIBA 11/2020 - 02/2020
2	Messenger RNA (mRNA)IBA 10/2020 - 02/2004
2	Programmed Cell Death 1 ReceptorIBA 08/2020 - 10/2018
2	Androgen Receptors (Androgen Receptor)IBA 11/2019 - 01/2018
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 05/2011
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2016 - 04/2008
2	N-(2-mercaptoethyl)-1,3-diaminopropaneIBA 10/2016 - 01/2004
2	Temozolomide (Temodar)FDA LinkGeneric 03/2016 - 01/2015
2	AntibodiesIBA 01/2014 - 04/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2013 - 05/2010

Therapy/Procedure

71	Radiotherapy 06/2022 - 01/2002
29	Drug Therapy (Chemotherapy) 08/2021 - 01/2002
15	Therapeutics 09/2021 - 05/2002
7	Immunotherapy 09/2021 - 07/2019
7	Chemoradiotherapy 08/2018 - 08/2002
2	Adjuvant Chemotherapy 05/2022 - 02/2004
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2021 - 03/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2021 - 06/2007